XORTX Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 09/02/2026 | 23.12 K | $52.47 K | 100.00% | 1.43% |
| STONEX GROUP INC. | 08/12/2026 | 16.37 K | $37.90 K | 100.00% | 1.01% |
| ROYAL BANK OF CANADA | 08/14/2026 | 732 | $2.00 K | 100.00% | 0.05% |
| NATIONAL BANK OF CANADA /FI/ | 08/10/2026 | 162 | $329 | 100.00% | 0.01% |
| CLEARSTEAD ADVISORS, LLC | 08/06/2026 | 55 | $120 | -80.14% | 0.00% |
| TD WATERHOUSE CANADA INC. | 07/27/2026 | 9 | $19 | 100.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 07/27/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
XORTX Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of XORTX Therapeutics Inc. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 23,116
StoneX Group Inc.: 16,369
ROYAL BANK OF CANADA: 732
NATIONAL BANK OF CANADA /FI/: 162
Clearstead Advisors, LLC: 55
TD Waterhouse Canada Inc.: 9
2.50% of XORTX Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 40.44 K shares in the last 24 months. This purchase volume represents approximately $18.60 K in transactions.